Cancer News
Pixantrone Progresses Toward Approval in the European Union

Can Aspirin Slow Cancer Progression?

Vemurafenib for Melanoma Approved in Europe

Uncertainty About Nutrition in Cancer Patients

Exercise: A Way to Outdistance Breast Cancer?
Strengthening The Intestinal Barrier May Prevent Cancer In The Rest Of The Body

Better Understanding Of Cancer Drugs Following Discovery Of Cell Energy Sensor Mechanism

Drugs That Affect Serotonin Signaling May Combat Bone Loss

For Patients With Advanced Hepatitis C, The Benefits Of Treatment Outweigh The Costs

Reformulated Imatinib Eliminates Morphine Tolerance In Lab Studies
PROFILE: Gay Crooks—Exploring the Human Side of Stem Cell Biology

Radiation Treatments Generate Cancer Stem Cells from Less Aggressive Breast Cancer Cells

AUDIO: Dr. Antoni Ribas Talks Potential Treatment Benefits of New Melanoma Drug that Accelerates Less Serious Skin Cancers

AUDIO: Athena Breast Health Network Launches Forum Series

VIDEO: Dr. Antoni Ribas Talks Secondary Skin Cancers with BRAF Inhibitor Zelboraf and How They Can Be Prevented
Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence

Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Social inequalities, tobacco chewing, and cancer mortality in south India: A case-control analysis of 2,580 cancer deaths among non-smoking non-drinkers

Kinetics of DNA adduct formation in the oral cavity after drinking alcohol

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
Translate
2012 No.1 Jan - Mar - Research

Hubungan Faktor Usia dengan Grading Histopatologi, Status Reseptor Hormonal, dan Ekspresi HER-2/neu pada Penderita Karsinoma Payudara di Rumah Sakit Onkologi Surabaya

JACOBUS OCTOVIANUS1, SINDRAWATI2, ARIO DJATMIKO1

1 Dokter Ahli Bedah Departemen Litbang Rumah Sakit Onkologi Surabaya
2 Dokter Ahli Patologi, Departemen Litbang Rumah Sakit Onkologi Surabaya

Diterima tanggal 2 Oktober 2011 ; Direview tanggal 3 Oktober 2011; Disetujui tanggal 7 November 2011

ABSTRACT

Introduction: age is one important prognostic factor in breast carcinoma. Objective: to assess the correlation of age to prognostic and predictive factors in breast carcinoma (the Hormonal Receptor Status, HER-2/neu over-xpression, and histopathological grading) in Rumah Sakit Onkologi Surabaya (RSOS). Methods: Retrospective study of medical record data of new breast carcinoma patients since January 2007 until December 2010. Data analysed were age, histopathological grading, hormonal receptor status and HER-2/neu over expression.

Results: 844 cases of 1426 new breast carcinoma cases at RSOS since January 2007 until December 2010 were concluded with histopathological and immunohistochemical reports for ER/PR status and HER-2/neu expression. The highest incidence was at the aged of 45-49 years (19%). The highest percentage of ER + (73.8%) at the aged of 40-44 years; ER- (45.5%) at <35 years; PR + (65.9%) at 40-44 years.;PR - (54.1%) at 60-64 years; HER-2/neu overexpression (36.4%) at 55-59; high histopathological grade (77.3%) at <35 years. ER +/PR + (19,6%) at 45-49 years and ER-/PR+ (42,8%) at 35-39 years. No significant correlation between age and tumor biological factors ; the ER/PR status, HER-2/neu overexpression, and histopathological grading (p>0.01). Conclusion: No significant correlation between age and tumor biological factors ; the hormonal receptor status, HER-2/neu and histopathological grading.

Keywords: breast carcinoma, age, hormonal receptors, histopathological grading, HER-2/neu

ABSTRAK

Usia merupakan salah satu faktor prognostik yang penting pada karsinoma payudara. Tujuan: menilai hubungan antara faktor usia dengan faktor yang berkaitan dengan prognosis dan faktor prediksi, yaitu status reseptor hormonal, ekspresi HER-2/neu, dan grading histopatologi pada pasien yang datang ke Rumah Sakit Onkologi Surabaya (RSOS). Metode: penelitian retrospektif dengan mencatat data rekam medis penderita karsinoma payudara baru di RS Onkologi Surabaya, sejak Januari 2007 sampai Desember 2010. Data yang dicatat adalah usia, grading histopatologi, status reseptor hormonal, dan ekspresi HER-2/neu.

Hasil: di antara 1.426 penderita baru yang datang di RSOS sejak Januari 2007 sampai Desember 2010, terdapat 844 kasus yang dilakukan pemeriksaan histopatologi dan imunohistokimia untuk status reseptor hormonal ER/PR dan ekspresi HER-2/neu. Didapatkan angka kejadian terbanyak pada rentang usia 45-49 tahun yaitu 160 penderita (19%). Prosentase tertinggi dari status ER + pada rentang usia 40-44 tahun (73,8%); ER- pada usia <35 tahun (45,5%); PR + pada usia 40-44 tahun (65,9%); PR – pada usia 60-64 tahun (54,1%); overekspresi HER-2/neu pada usia 55-59 tahun (36,4%); dan grading histopatologi tinggi pada usia <35 tahun (77,3%). ER+/PR+ pada usia 45-49 (19,6%) dan ER-/PR+ pada usia 35-39 tahun (42,8%). Dari hasil analisis statistik tidak didapat hubungan yang signifikan antara usia dengan faktor biologi tumor, yaitu status ER/PR, HER-2/neu, dan grading histopatologi (p>0,01). Kesimpulan: tidak didapat hubungan yang signifikan antara usia dengan faktor biologi tumor, yaitu status ER/PR, HER-2/neu, dan grading histopatologi.

Kata kunci: karsinoma payudara, usia, reseptor hormonal, grading histopathologi, HER-2/neu

 

 

Please logon to read / download the full content.

If you do not have an account, you may:

  • subscribe to gain full access to all articles, or
  • click the button below to pay USD 5.5 and download this article

 
Login



Visitors Counter
mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
mod_vvisit_counterToday152
mod_vvisit_counterYesterday301
mod_vvisit_counterThis week987
mod_vvisit_counterLast week1671
mod_vvisit_counterThis month5532
mod_vvisit_counterLast month6495
mod_vvisit_counterAll days52930

We have: 2 guests online
Your IP: 38.107.179.221
 , 
Today: Feb 22, 2012